CIK 0001124524 · Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 880313393
- Phone
- (949) 232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Sawicki Mark W Chief Scientific Officer | Sale | −1,312 | $15.43 | $20K | 73,061 |
| 2024-03-15 | Sawicki Mark W Chief Scientific Officer | Grant or award | +5,750 | 78,811 | ||
| 2024-03-15 | Sawicki Mark W Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +11,500 | 11,500 | ||
| 2024-03-15 | Mandalam Ramkumar Director | Option exercise | +8,334 | $5.40 | $45K | 46,404 |
| 2024-03-15 | Mandalam Ramkumar Director | Sale | −3,217 | $14.68 | $47K | 43,187 |
| 2024-03-15 | Mandalam Ramkumar Director | Option exercise · Stock Option (right to buy) | −8,334 | 0 | ||
| 2024-03-15 | BADDOUR LINDA Director | Option exercise | +1,111 | 21,690 | ||
| 2024-03-15 | BADDOUR LINDA Director | Option exercise · Restricted Stock Rights | −1,111 | 0 | ||
| 2024-03-15 | SHELTON JERRELL President, CEO | Sale | −2,599 | $20.79 | $54K | 634,352 |
| 2024-03-15 | SHELTON JERRELL President, CEO | Grant or award | +14,901 | 649,253 | ||
| 2024-03-15 | SHELTON JERRELL President, CEO | Option exercise | +100,000 | $4.80 | $480K | 749,253 |
| 2024-03-15 | SHELTON JERRELL President, CEO | Sale | −54,440 | $15.04 | $819K | 694,813 |
| 2024-03-15 | SHELTON JERRELL President, CEO | Option exercise · Stock Option (right to buy) | −100,000 | 4,167 | ||
| 2024-03-15 | SHELTON JERRELL President, CEO | Grant or award · Stock Option (right to buy) | +33,524 | 33,524 | ||
| 2024-03-11 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −1,119 | $16.35 | $18K | 124,697 |
| 2024-03-11 | Sawicki Mark W Chief Scientific Officer | Sale | −1,418 | $16.35 | $23K | 74,373 |
| 2024-03-11 | SHELTON JERRELL President, CEO | Sale | −3,723 | $16.35 | $61K | 636,951 |
| 2024-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +2,666 | 125,816 | ||
| 2024-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Restricted Stock Rights | −2,666 | 2,667 | ||
| 2024-03-09 | Sawicki Mark W Chief Scientific Officer | Option exercise | +2,666 | 75,791 |
Page 10 of 13 · 254 trades